Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ekso Bionics Holdings (EKSO) Cost of Revenue (2016 - 2026)

Ekso Bionics Holdings has reported Cost of Revenue over the past 14 years, most recently at $2.4 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 18.26% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.1 million, a 17.45% decrease, with the full-year FY2025 number at $7.2 million, down 14.98% from a year prior.
  • Cost of Revenue reached $2.4 million in Q4 2025 per EKSO's latest filing, up from $1.7 million in the prior quarter.
  • The five-year high for Cost of Revenue was $4.5 million in Q4 2021, with the low at $675000.0 in Q1 2021.
  • The 5-year median for Cost of Revenue is $1.8 million (2022), against an average of $1.9 million.
  • Peak YoY movement for Cost of Revenue: skyrocketed 400.45% in 2021, then tumbled 47.82% in 2022.
  • Tracing EKSO's Cost of Revenue over 5 years: stood at $4.5 million in 2021, then crashed by 47.82% to $2.3 million in 2022, then dropped by 14.97% to $2.0 million in 2023, then soared by 50.78% to $3.0 million in 2024, then fell by 18.26% to $2.4 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $2.4 million, $1.7 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.